The 2019 mathematical oncology roadmap
暂无分享,去创建一个
Angela M. Jarrett | Jacob G. Scott | Stacey D. Finley | Raoul R. Wadhwa | Nikhil P. Krishnan | G. Biros | E. Moros | T. Yankeelov | D. Wodarz | R. Rabadán | R. Gatenby | N. Komarova | S. Finley | K. Swanson | A. Hawkins-Daarud | J. Glazier | P. Jeavons | R. Rockne | J. Tinsley Oden | H. Enderling | A. Marusyk | D. Hormuth | A. Jarrett | E. Lima | P. Macklin | M. Hinczewski | J. Caudell | Artem Kaznatcheev | J. Pelesko | D. Nichol | Luis Aparicio | N. Yoon | M. Bordyuh | K. Curtius | A. Anderson | I. Al Bakir | J. Sluka | A. M. Jarrett | Luis C. Aparicio
[1] A. Friedman,et al. TNF-α inhibitor reduces drug-resistance to anti-PD-1: A mathematical model , 2020, PloS one.
[2] B. Schrefler,et al. Extension of a multiphase tumour growth model to study nanoparticle delivery to solid tumours , 2020, PloS one.
[3] Marta F. Estrada,et al. Zebrafish Avatars towards Personalized Medicine—A Comparative Review between Avatar Models , 2020, Cells.
[4] Angela M. Jarrett,et al. Forecasting tumor and vasculature response dynamics to radiation therapy via image based mathematical modeling , 2020, Radiation Oncology.
[5] V. Zhdanov. Spatio-temporal aspects of the interplay of cancer and the immune system , 2019, Journal of Biological Physics.
[6] Sandra K. Johnston,et al. Quantifying Uncertainty and Robustness in a Biomathematical Model–Based Patient-Specific Response Metric for Glioblastoma , 2019, JCO clinical cancer informatics.
[7] Jacob G. Scott,et al. Antibiotic collateral sensitivity is contingent on the repeatability of evolution , 2019, Nature Communications.
[8] Robert A. Gatenby,et al. Optimizing Cancer Treatment Using Game Theory: A Review , 2019, JAMA oncology.
[9] Emmanuel Barillot,et al. PhysiBoSS: a multi-scale agent-based modelling framework integrating physical dimension and cell signalling , 2018, bioRxiv.
[10] H. Enderling,et al. The accelerating quest for optimal radiation and immunotherapy combinations for local and systemic tumor control , 2018 .
[11] Jason K. Sa,et al. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma , 2018, Neuro-oncology.
[12] M. Ceccarelli,et al. Single-cell transcriptome analysis of lineage diversity in high-grade glioma , 2018, Genome Medicine.
[13] Artem Kaznatcheev. Computational Complexity as an Ultimate Constraint on Evolution , 2019, Genetics.
[14] Paul Macklin,et al. Key challenges facing data-driven multicellular systems biology , 2018, GigaScience.
[15] Sandra K. Johnston,et al. Quantifying Uncertainty and Robustness in a Biomathematical Model Based Patient-Specific Response Metric for Glioblastoma , 2018, bioRxiv.
[16] Kujtim Latifi,et al. Predicting Patient-Specific Radiotherapy Protocols Based on Mathematical Model Choice for Proliferation Saturation Index , 2018, Bulletin of mathematical biology.
[17] P. A. Futreal,et al. Timing the Landmark Events in the Evolution of Clear Cell Renal Cell Cancer: TRACERx Renal , 2018, Cell.
[18] Robert A Gatenby,et al. Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies , 2017, bioRxiv.
[19] M. Medina. Mathematical modeling of cancer metabolism. , 2018, Critical reviews in oncology/hematology.
[20] T. Galla,et al. Computational Model of Progression to Multiple Myeloma Identifies Optimum Screening Strategies , 2018, JCO clinical cancer informatics.
[21] Artem Kaznatcheev,et al. Effective games and the confusion over spatial structure , 2018, Proceedings of the National Academy of Sciences.
[22] O. Brawley,et al. Screening and Early Detection , 2017 .
[23] T. Graham,et al. An evolutionary perspective on field cancerization , 2017, Nature Reviews Cancer.
[24] M. Hochberg,et al. Spatial competition constrains resistance to targeted cancer therapy , 2017, Nature Communications.
[25] Joel s. Brown,et al. Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer , 2017, Nature Communications.
[26] Ignacio A. Rodriguez-Brenes,et al. The role of telomere shortening in carcinogenesis: A hybrid stochastic-deterministic approach , 2017, bioRxiv.
[27] Leland S. Hu,et al. NIMG-74. RADIOMICS OF TUMOR INVASION 2.0: COMBINING MECHANISTIC TUMOR INVASION MODELS WITH MACHINE LEARNING MODELS TO ACCURATELY PREDICT TUMOR INVASION IN HUMAN GLIOBLASTOMA PATIENTS , 2017 .
[28] Jeffrey West,et al. Capitalizing on Competition: An Evolutionary Model of Competitive Release in Metastatic Castrate Resistant Prostate Cancer Treatment , 2017, bioRxiv.
[29] Avlant Nilsson,et al. Genome scale metabolic modeling of cancer. , 2017, Metabolic engineering.
[30] Randy Heiland,et al. PhysiCell: An open source physics-based cell simulator for 3-D multicellular systems , 2017, bioRxiv.
[31] P. Altrock,et al. Extinction rates in tumour public goods games , 2017, Journal of The Royal Society Interface.
[32] Sayed-Amir Marashi,et al. A multiscale agent-based framework integrated with a constraint-based metabolic network model of cancer for simulating avascular tumor growth. , 2017, Molecular bioSystems.
[33] David Basanta,et al. Fibroblasts and Alectinib switch the evolutionary games played by non-small cell lung cancer , 2017, Nature Ecology & Evolution.
[34] B. Czerniecki,et al. Neoadjuvant radiotherapy of early-stage breast cancer and long-term disease-free survival , 2017, Breast Cancer Research.
[35] Ramón Díaz-Uriarte,et al. Cancer progression models and fitness landscapes: a many-to-many relationship , 2017, bioRxiv.
[36] Sharon S. Hori,et al. A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers. , 2017, Cancer research.
[37] P. Altrock,et al. Extinction rates in tumor public goods games , 2017, bioRxiv.
[38] Elena K. Kandror,et al. Single-cell topological RNA-Seq analysis reveals insights into cellular differentiation and development , 2017, Nature Biotechnology.
[39] Eduardo G Moros,et al. The future of personalised radiotherapy for head and neck cancer. , 2017, The Lancet. Oncology.
[40] Stacey D. Finley,et al. Computational Model Predicts the Effects of Targeting Cellular Metabolism in Pancreatic Cancer , 2017, Front. Physiol..
[41] Jacob G. Scott,et al. Somatic clonal evolution: A selection-centric perspective. , 2017, Biochimica et biophysica acta. Reviews on cancer.
[42] Jacob G. Scott,et al. A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study. , 2017, The Lancet. Oncology.
[43] Pablo G. Cámara,et al. Topological methods for genomics: present and future directions. , 2017, Current opinion in systems biology.
[44] Naveen Garg,et al. Leukemia cell proliferation and death in chronic lymphocytic leukemia patients on therapy with the BTK inhibitor ibrutinib. , 2017, JCI insight.
[45] Marc J. Williams,et al. Quantification of subclonal selection in cancer from bulk sequencing data , 2018, Nature Genetics.
[46] Alexander G. Fletcher,et al. MultiCellDS: a standard and a community for sharing multicellular data , 2016, bioRxiv.
[47] E. Dougherty,et al. Big data need big theory too , 2016, Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences.
[48] Alexander R A Anderson,et al. Phase i trials in melanoma: A framework to translate preclinical findings to the clinic. , 2016, European journal of cancer.
[49] M. Nowak,et al. An exactly solvable, spatial model of mutation accumulation in cancer , 2016, Scientific Reports.
[50] T E Yankeelov,et al. Selection, calibration, and validation of models of tumor growth. , 2016, Mathematical models & methods in applied sciences : M3AS.
[51] Oskar Hallatschek,et al. Excess of mutational jackpot events in expanding populations revealed by spatial Luria–Delbrück experiments , 2016, Nature Communications.
[52] Leland S. Hu,et al. Radiogenomics to characterize regional genetic heterogeneity in glioblastoma , 2016, Neuro-oncology.
[53] In-Hee Lee,et al. Clonal evolution of glioblastoma under therapy , 2016, Nature Genetics.
[54] J. McPherson,et al. Coming of age: ten years of next-generation sequencing technologies , 2016, Nature Reviews Genetics.
[55] Jianzhi Zhang,et al. The fitness landscape of a tRNA gene , 2016, Science.
[56] E. Hwang,et al. Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis. , 2016, Journal of the National Cancer Institute.
[57] W. Reik,et al. Single-cell epigenomics: powerful new methods for understanding gene regulation and cell identity , 2016, Genome Biology.
[58] Erik Schultes,et al. The FAIR Guiding Principles for scientific data management and stewardship , 2016, Scientific Data.
[59] R. Gillies,et al. Exploiting evolutionary principles to prolong tumor control in preclinical models of breast cancer , 2016, Science Translational Medicine.
[60] W. Koh,et al. Single-cell genome sequencing: current state of the science , 2016, Nature Reviews Genetics.
[61] Philipp M. Altrock,et al. The mathematics of cancer: integrating quantitative models , 2015, Nature Reviews Cancer.
[62] Teresa Wu,et al. Multi-Parametric MRI and Texture Analysis to Visualize Spatial Histologic Heterogeneity and Tumor Extent in Glioblastoma , 2015, PloS one.
[63] Thomas E Yankeelov,et al. Predicting the Response of Breast Cancer to Neoadjuvant Therapy Using a Mechanically Coupled Reaction-Diffusion Model. , 2015, Cancer research.
[64] Yonghua Wang,et al. Multi-scale modeling of cell survival and death mediated by the p53 network: a systems pharmacology framework. , 2015, Molecular bioSystems.
[65] Alexander G. Fletcher,et al. Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance , 2015, PLoS Comput. Biol..
[66] Kujtim Latifi,et al. A proliferation saturation index to predict radiation response and personalize radiotherapy fractionation , 2015, Radiation oncology.
[67] Jihyoun Jeon,et al. A Multiscale Model Evaluates Screening for Neoplasia in Barrett’s Esophagus , 2015, PLoS Comput. Biol..
[68] Robert J Gillies,et al. Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes. , 2015, Cancer research.
[69] Thomas E Yankeelov,et al. Toward a science of tumor forecasting for clinical oncology. , 2015, Cancer research.
[70] M. Archetti,et al. Heterogeneity for IGF-II production maintained by public goods dynamics in neuroendocrine pancreatic cancer , 2015, Proceedings of the National Academy of Sciences.
[71] Kristin R. Swanson,et al. Patient-Specific Metrics of Invasiveness Reveal Significant Prognostic Benefit of Resection in a Predictable Subset of Gliomas , 2014, PloS one.
[72] Dominik Wodarz,et al. Evolution of ibrutinib resistance in chronic lymphocytic leukemia (CLL) , 2014, Proceedings of the National Academy of Sciences.
[73] K. Polyak,et al. Non-cell autonomous tumor-growth driving supports sub-clonal heterogeneity , 2014, Nature.
[74] D. Wodarz,et al. Complex role of space in the crossing of fitness valleys by asexual populations , 2014, Journal of The Royal Society Interface.
[75] Natalia L. Komarova,et al. Dynamics of Cancer: Mathematical Foundations of Oncology , 2014 .
[76] Abbas Shirinifard,et al. The cell behavior ontology: describing the intrinsic biological behaviors of real and model cells seen as active agents , 2014, Bioinform..
[77] Jakub Otwinowski,et al. Inferring fitness landscapes by regression produces biased estimates of epistasis , 2014, Proceedings of the National Academy of Sciences.
[78] William Hazelton,et al. Benefits and Harms of Computed Tomography Lung Cancer Screening Strategies: A Comparative Modeling Study for the U.S. Preventive Services Task Force , 2014, Annals of Internal Medicine.
[79] B. Ross,et al. Mathematical Modeling of PDGF-Driven Glioblastoma Reveals Optimized Radiation Dosing Schedules , 2014, Cell.
[80] David Basanta,et al. Edge effects in game-theoretic dynamics of spatially structured tumours , 2013, Journal of The Royal Society Interface.
[81] Kristin R. Swanson,et al. Response classification based on a minimal model of glioblastoma growth is prognostic for clinical outcomes and distinguishes progression from pseudoprogression. , 2013, Cancer research.
[82] Christopher S. Poultney,et al. A physical sciences network characterization of non-tumorigenic and metastatic cells , 2013, Scientific Reports.
[83] L. Hanin,et al. Optimal screening schedules for prevention of metastatic cancer , 2013, Statistics in medicine.
[84] Kristin R. Swanson,et al. Discriminating Survival Outcomes in Patients with Glioblastoma Using a Simulation-Based, Patient-Specific Response Metric , 2013, PloS one.
[85] K. R. Swanson,et al. From Patient-Specific Mathematical Neuro-Oncology to Precision Medicine , 2013, Front. Oncol..
[86] J. R. Ledford. Quantitative MRI in Cancer , 2012 .
[87] S. Demaria,et al. Radiation therapy to convert the tumor into an in situ vaccine. , 2012, International journal of radiation oncology, biology, physics.
[88] B. Bot,et al. Use of a novel patient-specific model of glioma growth kinetics to elucidate underlying biology as measured by gene expression microarray. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[89] H. Antti,et al. LAB–OMICS AND PROGNOSTIC MARKERS , 2012 .
[90] David Basanta,et al. Exploiting evolution to treat drug resistance: combination therapy and the double bind. , 2012, Molecular pharmaceutics.
[91] Alexander R A Anderson,et al. Quantifying the Role of Angiogenesis in Malignant Progression of Gliomas: in Silico Modeling Integrates Imaging and Histology Nih Public Access Author Manuscript Introduction , 2011 .
[92] Jacob G. Scott,et al. Investigating prostate cancer tumour–stroma interactions: clinical and biological insights from an evolutionary game , 2011, British Journal of Cancer.
[93] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[94] K Hendrickson,et al. Predicting the efficacy of radiotherapy in individual glioblastoma patients in vivo: a mathematical modeling approach , 2010, Physics in medicine and biology.
[95] A. Deutsch,et al. Studying the emergence of invasiveness in tumours using game theory , 2008, 0810.4724.
[96] E. Luebeck,et al. Evaluation of screening strategies for pre-malignant lesions using a biomathematical approach. , 2008, Mathematical biosciences.
[97] V. Quaranta,et al. Integrative mathematical oncology , 2008, Nature Reviews Cancer.
[98] Steven A. Frank,et al. Dynamics of Cancer , 2007 .
[99] S. McDougall,et al. Mathematical modeling of tumor-induced angiogenesis. , 2006, Annual review of biomedical engineering.
[100] Nigel F. Delaney,et al. Darwinian Evolution Can Follow Only Very Few Mutational Paths to Fitter Proteins , 2006, Science.
[101] Douglas A. Creager,et al. The Open Microscopy Environment (OME) Data Model and XML file: open tools for informatics and quantitative analysis in biological imaging , 2005, Genome Biology.
[102] Tom R. Miller,et al. PET: Molecular Imaging and Its Biological Applications. , 2005 .
[103] S. Levy,et al. Antibacterial resistance worldwide: causes, challenges and responses , 2004, Nature Medicine.
[104] D L S McElwain,et al. A history of the study of solid tumour growth: The contribution of mathematical modelling , 2004, Bulletin of mathematical biology.
[105] Catherine M Lloyd,et al. CellML: its future, present and past. , 2004, Progress in biophysics and molecular biology.
[106] Michael E. Phelps,et al. PET: Molecular Imaging and Its Biological Applications , 2004 .
[107] H. Othmer,et al. Mathematical modeling of tumor-induced angiogenesis , 2004, Journal of mathematical biology.
[108] C. Pedersen. Unleashing the 'love' hormone , 2004, Nature Medicine.
[109] Hiroaki Kitano,et al. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models , 2003, Bioinform..
[110] Helen Parkinson,et al. The MGED Ontology: A Framework for Describing Functional Genomics Experiments , 2003, Comparative and functional genomics.
[111] M. Williams,et al. Basic clinical radiobiology , 1994, British Journal of Cancer.
[112] Danny R. Welch. Tumor Heterogeneity--A 'Contemporary Concept' Founded on Historical Insights and Predictions. , 2016, Cancer research.
[113] Ronald M. Summers,et al. Kidney Tumor Growth Prediction by Coupling Reaction–Diffusion and Biomechanical Model , 2013, IEEE Transactions on Biomedical Engineering.
[114] B. Frieden,et al. Adaptive therapy. , 2009, Cancer research.
[115] Facundo Mémoli,et al. Topological Methods for the Analysis of High Dimensional Data Sets and 3D Object Recognition , 2007, PBG@Eurographics.
[116] P M Nadkarni,et al. The Common Data Elements for Cancer Research: Remarks on Functions and Structure , 2006, Methods of Information in Medicine.
[117] Michael E. Phelps,et al. PET , 2004, Springer New York.
[118] M. Tattersall,et al. Screening and Early Detection , 1994 .